These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18601631)

  • 1. The changing landscape for cervical screening.
    Farnsworth A
    Med J Aust; 2008 Jul; 189(1):6-7. PubMed ID: 18601631
    [No Abstract]   [Full Text] [Related]  

  • 2. For debate: that Australia should continue using the quadrivalent vaccine.
    Wain G
    Sex Health; 2010 Sep; 7(3):235-7. PubMed ID: 21058496
    [No Abstract]   [Full Text] [Related]  

  • 3. Global human papillomavirus vaccination: can it be cost-effective?
    Crosbie EJ
    BJOG; 2012 Jan; 119(2):125-8. PubMed ID: 22168760
    [No Abstract]   [Full Text] [Related]  

  • 4. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ladies first: should boys be vaccinated against HPV?
    Leon R
    Can Fam Physician; 2008 Jul; 54(7):967-8, 972-3. PubMed ID: 18625809
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening: Testing times.
    Humphries C
    Nature; 2012 Aug; 488(7413):S8-9. PubMed ID: 22932440
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
    Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
    Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summaries for patients. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.
    Ann Intern Med; 2009 Oct; 151(8):I36. PubMed ID: 19841439
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on "New paradigm for prevention of cervical cancer" [Eur J Obstet Gynecol Reprod Biol 2007;130(1):25-9].
    Mahajan NN; Gaikwad NL; Soni RN; Mahajan KN
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):140-1; author reply 141. PubMed ID: 17524549
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cervix cancer can be prevented. Efficient HPV tests and highly-protective vaccine soon available for clinical use].
    Bistoletti P
    Lakartidningen; 2006 May 3-9; 103(18):1402. PubMed ID: 16729451
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland.
    Szucs TD; Largeron N; Dedes KJ; Rafia R; Bénard S
    Curr Med Res Opin; 2008 May; 24(5):1473-83. PubMed ID: 18413014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebuttal: Do you approve of spending $300 million on HPV vaccination? Yes.
    Steben M
    Can Fam Physician; 2008 Mar; 54(3):342, 344. PubMed ID: 18337521
    [No Abstract]   [Full Text] [Related]  

  • 14. Does it matter? Discounting and its role in the cost-effectiveness of preventative interventions. The case of HPV vaccination.
    Starkie Camejo H; Li X; Van Kriekinge G
    Public Health; 2015 Jul; 129(7):989-92. PubMed ID: 25834927
    [No Abstract]   [Full Text] [Related]  

  • 15. Human papillomavirus vaccination: where to now?
    Garland SM
    Sex Transm Infect; 2011 Dec; 87 Suppl 2(Suppl 2):ii23-4. PubMed ID: 22110148
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
    Oteng B; Marra F; Lynd LD; Ogilvie G; Patrick D; Marra CA
    Sex Transm Infect; 2011 Feb; 87(1):52-7. PubMed ID: 20956352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus testing, vaccination, and gynecologic screening: fight or flight?
    Covell JL; Stoler MH
    Am J Clin Pathol; 2007 Nov; 128(5):726-8. PubMed ID: 17951192
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy debate over human papillomavirus vaccines.
    Richman S
    J Low Genit Tract Dis; 2009 Apr; 13(2):128. PubMed ID: 19387138
    [No Abstract]   [Full Text] [Related]  

  • 19. Cervical cancer control in India: taking evidence to action.
    Farooqui HH; Zodpey S
    J Public Health Policy; 2012 May; 33(2):165-72. PubMed ID: 22555096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on opinion pieces re Australian human papillomavirus vaccine policy.
    McIntyre P
    Sex Health; 2010 Sep; 7(3):242-3. PubMed ID: 21058498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.